Clinical OMICs - Volume 3, Issue 9 - 33

Clinical OMICs MEETING ROUNDUP September 19-21 Festival of Genomics California San Diego Festival of Genomics Caifornia is a free-to-attend genomics meeting and exhibition featuring nine topical tracks including Genomic Medicine, Cancer Genomics, Enabling Data, Transcriptomics, Editing the Genome, Single Cell Analysis, and Drug Development, among others. It also features TechForum, quick-fire presentations, a special seminar on artificial intelligence (AI), hands on demonstrations in the Live Lab and an exhibition floor with more than 50 exhibitors focused on providing tools and services to the fast growing genomics market. September 25-28, 2016 Baltimore The Genomics of Common Diseases 2016 High-throughput genotyping and sequencing technologies have profoundly impacted our understanding of the genetic architecture of disease. This year's conference will be an opportunity to reflect back on the past decade of genomic studies and to consider how new and emerging technologies will yield further insights into disease pathophysiology with potential for clinical impact. The meeting will feature leading examples of genetic discovery efforts for common diseases using a range of technologies and study designs. The program will also highlight approaches to characterize regulatory variation, strategic uses of experimental systems to increase mechanistic understanding of disease, and important recent efforts in clinical translation. www.clinicalomics.com October 18-21 World CDx Boston 2016 Boston World CDx Boston Summit 2016 offers content dedicated to help industry participants progress from exploratory biomarker to registrational CDx, align clinical co-development and ensure reimbursement and market access success for your precision therapies and assays. With the rise of liquid biopsies, NGS and other multi-omic technologies, overcome disease heterogeneity and validate exploratory biomarkers to accurately stratify your therapy and future CDx. The conference offers different learning streams including the Biomarker Discovery & Validation Stream, the Clinical Co-Development Stream, and the Precision Medicine Commercialization Stream. Through senior level networking and unrivalled learning, define your most efficient CDx roadmap. Improve your discovery, development, and commercialization of biomarker-based precision therapies and assays. October 18-22 ASHG Vancouver The 66th Annual Meeting of the American Society of Human Genetics is the largest human genetics meeting and exposition in the world. This year's meeting is expected to attract more than 6,500 scientific attendees, plus 200 exhibiting companies. The meeting provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. ASHG members and leading scientists from around the world are selected to present their research findings at invited, platform, and poster sessions. Abstracts presented at the Annual Meeting are published online and are citable. ASHG's Annual Meeting also features a trade show floor that offers attendees the opportunity to view state-ofthe-art medical and laboratory equipment, products, services, and computer software designed to enhance human genetics research, teaching, and consultation. September 2016 Clinical OMICs 33 http://www.festivalofgenomicscalifornia.com/welcome http://world-cdx.com/ http://www.nature.com/natureconferences/gcd2016/index.html http://www.ashg.org/2016meeting/ http://www.clinicalomics.com

Table of Contents for the Digital Edition of Clinical OMICs - Volume 3, Issue 9

Contents
Clinical OMICs - Volume 3, Issue 9 - Cover1
Clinical OMICs - Volume 3, Issue 9 - Cover2
Clinical OMICs - Volume 3, Issue 9 - Contents
Clinical OMICs - Volume 3, Issue 9 - 4
Clinical OMICs - Volume 3, Issue 9 - 5
Clinical OMICs - Volume 3, Issue 9 - 6
Clinical OMICs - Volume 3, Issue 9 - 7
Clinical OMICs - Volume 3, Issue 9 - 8
Clinical OMICs - Volume 3, Issue 9 - 9
Clinical OMICs - Volume 3, Issue 9 - 10
Clinical OMICs - Volume 3, Issue 9 - 11
Clinical OMICs - Volume 3, Issue 9 - 12
Clinical OMICs - Volume 3, Issue 9 - 13
Clinical OMICs - Volume 3, Issue 9 - 14
Clinical OMICs - Volume 3, Issue 9 - 15
Clinical OMICs - Volume 3, Issue 9 - 16
Clinical OMICs - Volume 3, Issue 9 - 17
Clinical OMICs - Volume 3, Issue 9 - 18
Clinical OMICs - Volume 3, Issue 9 - 19
Clinical OMICs - Volume 3, Issue 9 - 20
Clinical OMICs - Volume 3, Issue 9 - 21
Clinical OMICs - Volume 3, Issue 9 - 22
Clinical OMICs - Volume 3, Issue 9 - 23
Clinical OMICs - Volume 3, Issue 9 - 24
Clinical OMICs - Volume 3, Issue 9 - 25
Clinical OMICs - Volume 3, Issue 9 - 26
Clinical OMICs - Volume 3, Issue 9 - 27
Clinical OMICs - Volume 3, Issue 9 - 28
Clinical OMICs - Volume 3, Issue 9 - 29
Clinical OMICs - Volume 3, Issue 9 - 30
Clinical OMICs - Volume 3, Issue 9 - 31
Clinical OMICs - Volume 3, Issue 9 - 32
Clinical OMICs - Volume 3, Issue 9 - 33
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue15
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue14
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue13
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue1
https://www.nxtbookmedia.com